Renalytix plc — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e9270464-78a3-4e99-9ae1-7d8f009d8d36/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-29.6M | 2023-07-01 – 2024-06-30 | evidence 0000950170-24-110315 |
| FY 2023 | $-42.2M | 2022-07-01 – 2023-06-30 | evidence 0000950170-23-050231 |
| FY 2022 | $-53.2M | 2021-07-01 – 2022-06-30 | evidence 0000950170-22-020618 |
| FY 2021 | $-31.9M | 2020-07-01 – 2021-06-30 | evidence 0001193125-21-303600 |
| FY 2020 | $-10.3M | 2019-07-01 – 2020-06-30 | evidence 0001193125-20-289263 |
| FY 2019 | $-42.3M | 2018-07-01 – 2019-06-30 | evidence 0001193125-20-289263 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).